Current Technology

Current Technology Corporation was a medical device company primarily known for developing the TrichoGenesis platform, a non-invasive pulsed electro-stimulation technology designed to treat hair loss. Its flagship product, the ElectroTrichoGenesis (ETG) device, utilized pulsed electrostatic fields to stimulate hair follicles and was marketed for androgenetic alopecia and chemotherapy-induced hair loss. The company also developed a cosmetic version of the technology known as CosmeticTrichoGenesis (CTG) for the salon and spa market. While the company achieved regulatory approvals in several international markets, including Canada and Europe, it faced challenges in securing full FDA clearance for medical claims in the United States. Current Technology Corporation was publicly traded on the OTC Bulletin Board under the symbol CRTCF before becoming inactive.